Quality control - a stepchild in quantitative proteomics : a case study for the human CSF proteome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Biomolecules, 13, 3, Article 491, S. 491-1-491-20
- Ereignis
-
Veröffentlichung
- (wo)
-
Bochum
- (wer)
-
Ruhr-Universität Bochum
- (wann)
-
2023
- Urheber
-
Rozanova, Svitlana
Uszkoreit, Julian
Schork, Karin
Serschnitzki, Bettina
Eisenacher, Martin
Tönges, Lars
Barkovits, Katalin
Marcus, Katrin
- URN
-
urn:nbn:de:hbz:294-105016
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:41 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rozanova, Svitlana
- Uszkoreit, Julian
- Schork, Karin
- Serschnitzki, Bettina
- Eisenacher, Martin
- Tönges, Lars
- Barkovits, Katalin
- Marcus, Katrin
- Ruhr-Universität Bochum
Entstanden
- 2023
Ähnliche Objekte (12)
Unravelling the complexity of the CSF-Proteome
The connected steady state model and the interdependence of the CSF proteome and CSF flow characteristics
Plasma Proteome Analysis Using Peptide Group-Specific Immunoprecipitation "Triple X Proteomics"
Analysis of aging by quantitative proteomics and mitochondrial organellar proteomics
Analysis of aging by quantitative proteomics and mitochondrial organellar proteomics
From genome to proteome : advances in the practice and application of proteomics
Quantitative chemical proteomics for cancer characterization
Quantitative chemical proteomics for cancer characterization
Benchmarking and application of quantitative mass spectrometry-based proteomics methods for cohort-wide proteome studies and intrinsic identification of limited proteolysis
Quantitative interaction proteomics of neurodegenerative disease proteins
Quantitative interaction proteomics of neurodegenerative disease proteins
Investigations of genome instability utilizing quantitative proteomics
Unravelling the complexity of the CSF-Proteome
The connected steady state model and the interdependence of the CSF proteome and CSF flow characteristics
Plasma Proteome Analysis Using Peptide Group-Specific Immunoprecipitation "Triple X Proteomics"
Analysis of aging by quantitative proteomics and mitochondrial organellar proteomics
Analysis of aging by quantitative proteomics and mitochondrial organellar proteomics
From genome to proteome : advances in the practice and application of proteomics
Quantitative chemical proteomics for cancer characterization
Quantitative chemical proteomics for cancer characterization
Benchmarking and application of quantitative mass spectrometry-based proteomics methods for cohort-wide proteome studies and intrinsic identification of limited proteolysis
Quantitative interaction proteomics of neurodegenerative disease proteins
Quantitative interaction proteomics of neurodegenerative disease proteins
Investigations of genome instability utilizing quantitative proteomics
Unravelling the complexity of the CSF-Proteome
The connected steady state model and the interdependence of the CSF proteome and CSF flow characteristics
Plasma Proteome Analysis Using Peptide Group-Specific Immunoprecipitation "Triple X Proteomics"
Analysis of aging by quantitative proteomics and mitochondrial organellar proteomics
Analysis of aging by quantitative proteomics and mitochondrial organellar proteomics
From genome to proteome : advances in the practice and application of proteomics
Quantitative chemical proteomics for cancer characterization
Quantitative chemical proteomics for cancer characterization
Benchmarking and application of quantitative mass spectrometry-based proteomics methods for cohort-wide proteome studies and intrinsic identification of limited proteolysis
Quantitative interaction proteomics of neurodegenerative disease proteins
Quantitative interaction proteomics of neurodegenerative disease proteins